Privi Speciality Chemicals announced financial results for the quarter and nine-month period.

The Board approved a Rs 50 Cr equity investment in its subsidiary, Prigiv Specialties, with Privi investing Rs 25.5 Cr.

This capital infusion will support Prigiv's growth plans, aiming for higher revenue and improved profitability.